Cone snails deploy sophisticated venom cocktails to paralyse prey. Anthony King talks to the researchers harnessing these peptides to develop new pain medications
Cone snails wield some of the most chemically complex venoms in nature, and researchers are now uncovering how their potent peptides could inspire a new generation of non‑addictive pain treatments. These miniature biological ‘cocktails’ can target multiple receptors with remarkable precision, and recent advances in peptide engineering, structural biology and delivery methods are helping overcome long‑standing barriers to turning them into medicines. Although only one snail‑derived drug has reached patients so far, scientists say the field is undergoing a renaissance – and that these evolution‑honed molecules may yet offer relief for some of the most stubborn and debilitating chronic pain conditions.